Vein specialist NYC
Scheer Medical Wellness (NYC Stem Cells) is a New York City regenerative medicine practice offering cash-pay autologous stem cell and exosome therapy for conditions ranging from arthritis and neurodegenerative disease to anti-aging, under Medical Director Dr. Alexandre Scheer.
- Company typePrivate
- Founded2005
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Vein specialist NYC does
Scheer Medical Wellness, operating under the trade name NYC Stem Cells, is a New York City-based regenerative medicine practice founded by Dr. Alexandre Scheer, MD. The clinic provides autologous stem cell therapy (harvested from the patient's own bone marrow or adipose tissue) and exosome therapy derived from stem cells, delivered at a single midtown Manhattan facility at 39 West 38th Street. It treats a broad range of conditions including arthritis and orthopedic issues, back pain, neurodegenerative diseases (Parkinson's, Alzheimer's, MS), stroke recovery, diabetes, autoimmune diseases, autism, and anti-aging indications.
The underlying technology combines surgical extraction (iliac-crest bone marrow aspiration or liposuction-based adipose harvest), centrifugation-based cell processing, enzymatic concentration of adipose-derived stem cells, and combination with platelet-rich plasma before targeted injection. Exosome therapy adds stem-cell-derived extracellular vesicles processed through ultracentrifugation and programmed to communicate with target cells. The practice emphasizes a single-physician clinical model under Dr. Scheer's medical direction, supplemented by a COO, a DNP candidate, and a licensed acupuncturist.
The business model is direct-to-consumer and entirely cash-pay: stem cell and exosome procedures are not covered by health insurance as they are considered experimental, and the practice mitigates affordability friction through third-party financing partners LightStream and PatientFi. Go-to-market relies on organic content (blog, video library, research citations), social media (Facebook, Instagram), podcast appearances, and patient testimonials rather than paid institutional channels. The practice has no disclosed funding, no parent company, and operates as an independently owned private medical practice serving individual patients on a per-procedure basis.
Vein specialist NYC firmographics
Firmographics- Name
- Vein specialist NYC
- Legal name
- Scheer Medical Wellness
- Website
- https://nycstemcells.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Scheer Medical Wellness (NYC Stem Cells) is a New York City regenerative medicine practice offering cash-pay autologous stem cell and exosome therapy for conditions ranging from arthritis and neurodegenerative disease to anti-aging, under Medical Director Dr. Alexandre Scheer.
- Ownership category
- akta.pro rank
Vein specialist NYC industry classification
Industry- Product category
- Regenerative Medicine
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
- akta.pro secondary industries
- Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)
Keywords
Where Vein specialist NYC is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Vein specialist NYC business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Consultation and Treatment Services: Direct patient payments for medical consultations, stem cell therapy procedures, exosome therapy treatments, and related regenerative medicine services. Services are not covered by health insurance as stem cell therapy is considered experimental.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Vein specialist NYC product offering
Product offeringCore offering
The company provides regenerative medicine treatments centered on autologous stem cell therapy and exosome therapy. Stem cells are harvested from the patient's own bone marrow (iliac-crest hip bone via needle insertion) or adipose tissue (liposuction from abdomen, thighs, buttocks, or hips), processed via centrifuge or enzyme exposure, and injected into targeted areas to repair damaged cells and tissues. Exosomes are extracted from stem cells, purified through ultracentrifugation, and programmed to communicate with target cells for anti-aging, wound healing, and disease modification applications.
Product overview
Scheer Medical Wellness operates as a cutting-edge regenerative medicine practice offering three interconnected treatment modalities: Autologous Stem Cell Therapy (using the patient's own adipose tissue or bone marrow-derived stem cells), Exosome Therapy (using stem cell-derived extracellular vesicles), and general Stem Cell Therapy. These treatments activate the body's natural healing mechanisms to repair damaged cells and tissues. The practice specializes in treating a wide range of conditions including arthritis, back pain, autoimmune diseases, neurodegenerative disorders (Parkinson's, Alzheimer's, MS), autism, diabetes, and stroke recovery. All treatments are administered at their New York City facility under the supervision of Medical Director Dr. Alexandre Scheer, MD.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 50+ patients with 5-star reviews reported positive treatment outcomes
- +2 more outcomes
Companies that use Vein specialist NYC
Customer profileNamed customers9 records
Segments7 records
Ideal customer profiles1 record
Vein specialist NYC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vein specialist NYC partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- ON Digital AgencyminorWebsite development and digital marketing agency responsible for the practice's website design and maintenance.
- MedLuxe InstituteminorHealthcare strategy organization where Kathleen Francesca serves as President. Kathleen also serves as COO of NY Stem Cells, creating a strategic connection in healthcare strategy and media.
- Nouveau Wellness ConciergeminorGlobal wellness concierge platform founded by COO Kathleen Francesca, connecting clients to advanced medical, regenerative, and wellness solutions worldwide with presence in US, Latin America, and Asia.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Vein specialist NYC competitors and assessment
Company assessmentDirect peers
- NSI Stem Cell: NSI Stem Cell operates multiple U.S. clinics delivering autologous adult stem cell therapy for a wide range of chronic conditions, using a similar direct-to-consumer marketing and pricing approach.
- Regenexx: Regenexx operates a national network of clinics delivering autologous stem cell and platelet-rich plasma therapies for orthopedic and musculoskeletal conditions, with a direct-to-consumer cash-pay model similar to Scheer Medical Wellness.
- BioXcellerator: BioXcellerator is a stem cell therapy clinic offering autologous and cultured stem cell treatments for orthopedic, neurological, and autoimmune conditions with a cash-pay, premium-care delivery model.
- The Lung Institute: The Lung Institute is a cash-pay regenerative medicine clinic using autologous stem cell therapy for pulmonary and other chronic conditions, with similar direct-to-consumer marketing and self-pay patient dynamics.
- StemGenex: StemGenex runs a stem cell treatment clinic offering autologous adipose- and bone marrow-derived therapies for a broad range of conditions including autoimmune, neurological, and orthopedic indications, mirroring Scheer's positioning.
- Okyanos Stem Cell Center: Okyanos provides adult stem cell therapy using autologous adipose-derived cells for cardiac, orthopedic, and neurological conditions under a private-pay clinical model comparable to Scheer's practice.
- Celltex Therapeutics: Celltex Therapeutics provides autologous mesenchymal stem cell banking and therapy services, targeting similar regenerative medicine indications through a private-pay clinical delivery model.
Emerging players
- Personalized Stem Cells: Personalized Stem Cells develops FDA-IND-compliant autologous adipose-derived stem cell therapies with clinical trial programs, representing an emerging, more clinically rigorous counterpart in the same autologous therapy space.
Regional players
- Park Avenue Stem Cell: Park Avenue Stem Cell is a New York City-based regenerative medicine clinic offering autologous stem cell and PRP therapies; geographically overlapping with Scheer Medical Wellness in the Manhattan market.
- StemCells21: StemCells21 is a Bangkok-based regenerative medicine clinic offering autologous stem cell and exosome therapies to international medical-tourism patients, providing a comparable but geographically distinct treatment model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Vein specialist NYC social profiles
Digital presenceVein specialist NYC financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vein specialist NYC leadership team
Management profileNumber of profiles
Profiles4 records
Vein specialist NYC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vein specialist NYC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vein specialist NYC
What does Vein specialist NYC do?
The company provides regenerative medicine treatments centered on autologous stem cell therapy and exosome therapy. Stem cells are harvested from the patient's own bone marrow (iliac-crest hip bone via needle insertion) or adipose tissue (liposuction from abdomen, thighs, buttocks, or hips), processed via centrifuge or enzyme exposure, and injected into targeted areas to repair damaged cells and tissues. Exosomes are extracted from stem cells, purified through ultracentrifugation, and programmed to communicate with target cells for anti-aging, wound healing, and disease modification applications.
Is Vein specialist NYC a public or private company?
Vein specialist NYC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vein specialist NYC founded?
Vein specialist NYC was founded in 2005. It employs 51 to 100 people.
Where is Vein specialist NYC based?
Vein specialist NYC is headquartered in New York, United States, in the North America region.
How does Vein specialist NYC make money?
One revenue line is on record: medical Consultation and Treatment Services.
Who are Vein specialist NYC's main competitors?
Direct peers on record are NSI Stem Cell, Regenexx, BioXcellerator, The Lung Institute, StemGenex, Okyanos Stem Cell Center and Celltex Therapeutics. Personalized Stem Cells is listed as an emerging player. Regional players are Park Avenue Stem Cell and StemCells21.
Does Vein specialist NYC have an API?
No public API is recorded for Vein specialist NYC.
What industry is Vein specialist NYC in?
Vein specialist NYC's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAAABAJ, Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring). Its NAICS code is 621991.